Nodular lymphocyte predominant Hodgkin lymphoma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

3 events
Apr 2024Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

St. Jude Children's Research Hospital

TrialRECRUITING
Jan 2024Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

National Cancer Institute (NCI) — PHASE2

TrialRECRUITING
Jan 2006Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease

Children's Oncology Group — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Nodular lymphocyte predominant Hodgkin lymphoma.
Check the disease page for updates →

Clinical Trial Landscape

2 active trials
1Phase 2
1Unknown
2Total recruiting
Search clinical trials for Nodular lymphocyte predominant Hodgkin lymphoma

Recent News & Research

No recent news articles indexed yet for Nodular lymphocyte predominant Hodgkin lymphoma.
Search PubMed for Nodular lymphocyte predominant Hodgkin lymphoma

Browse all Nodular lymphocyte predominant Hodgkin lymphoma news →

Specialist Network

Top 6 by expertise

View all Nodular lymphocyte predominant Hodgkin lymphoma specialists →

Quick Actions